Insider Trading activities of Infinity Pharmaceuticals, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Infinity Pharmaceuticals, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Infinity Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Infinity Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is INFI. The reporting company's CIK number is 1113148.
The total value of stock buying since 2005 is $192,350,530.
The total value of stock sales since 2005 is $450,216,377.
The total value of stock option exercises since 2005 is $3,184,163.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Infinity Pharmaceuticals, Inc. (INFI).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-10 1,600,046 $2,008,075 0 $0 0 $0
2017-03 0 $0 6,250 $21,750 0 $0
2017-01 4,379 $5,867 0 $0 0 $0
2016-12 1,598,716 $2,086,187 75,000 $96,299 0 $0
2015-06 0 $0 9,737 $106,614 0 $0
2015-05 0 $0 20,000 $249,900 0 $0
2015-04 0 $0 0 $0 4,737 $9,663
2015-03 0 $0 45,000 $732,500 0 $0
2015-01 0 $0 20,000 $296,540 0 $0
2014-12 0 $0 4,737 $77,293 4,737 $9,663
2014-11 0 $0 4,736 $71,040 4,736 $9,661
2014-10 0 $0 0 $0 24,500 $303,677
2014-09 0 $0 121,923 $1,671,059 9,472 $19,322
2014-07 0 $0 879 $11,312 0 $0
2014-03 0 $0 0 $0 2,500 $22,174
2014-02 0 $0 4,736 $71,040 4,736 $9,661
2014-01 0 $0 753 $10,180 0 $0
2013-12 0 $0 17,756 $258,527 0 $0
2013-11 0 $0 163,864 $2,428,003 0 $0
2013-09 0 $0 49,736 $1,014,337 4,736 $9,661
2013-06 0 $0 23,150 $429,062 22,103 $38,017
2013-04 0 $0 11,416,565 $438,396,095 0 $0
2013-03 0 $0 0 $0 6,250 $105,000
2012-12 0 $0 0 $0 178,497 $1,272,280
2012-11 0 $0 36,365 $922,409 72,542 $625,750
2012-10 0 $0 0 $0 5,000 $44,349
2012-09 10,833,130 $157,080,384 0 $0 9,200 $59,800
2012-05 0 $0 257,834 $3,352,417 0 $0
2010-12 25,000 $151,800 0 $0 0 $0
2010-08 50,000 $245,034 0 $0 0 $0
2009-01 2,000,000 $30,000,000 0 $0 0 $0
2008-12 9,200 $72,671 0 $0 0 $0
2008-11 22,041 $134,080 0 $0 0 $0
2008-10 0 $0 0 $0 226,155 $645,485
2008-08 22,103 $163,562 0 $0 0 $0
2008-03 2,328 $13,764 0 $0 0 $0
2007-09 5,000 $45,599 0 $0 0 $0
2007-06 10,000 $106,380 0 $0 0 $0
2007-05 21,594 $237,127 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Infinity Pharmaceuticals, Inc. insiders (INFI)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-04 Lampert Mark N Buy 653,449 1.28 839,028
2017-10-03 Lampert Mark N Buy 946,597 1.24 1,169,047
2017-03-17 Venuti Michael C (Director) Sale 6,250 3.48 21,750
2017-01-03 Lampert Mark N Buy 4,379 1.34 5,867
2016-12-30 Lampert Mark N Buy 3,553 1.34 4,761
2016-12-28 Lampert Mark N Buy 738,848 1.34 987,100
2016-12-20 Lampert Mark N Buy 22,001 1.35 29,811
2016-12-19 Lampert Mark N Buy 198,264 1.36 269,242
2016-12-16 Lampert Mark N Buy 434,656 1.28 556,359
2016-12-13 Kango Sujay (Chief Commercial Officer) Sale 49,991 1.27 63,688
2016-12-12 Kango Sujay (Chief Commercial Officer) Sale 25,009 1.30 32,611
2016-12-02 Lampert Mark N Buy 52,500 1.19 62,475
2016-12-01 Lampert Mark N Buy 148,894 1.19 176,439
2015-06-25 Perkins Adelene Q (President & CEO) Sale 5,000 10.93 54,650
2015-06-15 Palombella Vito J. (Chief Scientific Officer) Sale 4,737 10.97 51,964
2015-05-27 Perkins Adelene Q (President & CEO) Sale 10,000 12.81 128,100
2015-05-14 Perkins Adelene Q (President & CEO) Sale 10,000 12.18 121,800
2015-04-30 Palombella Vito J. (Chief Scientific Officer) Option Ex 4,737 2.04 9,663
2015-03-16 Perkins Adelene Q (President & CEO) Sale 20,000 16.00 320,000
2015-03-05 Perkins Adelene Q (President & CEO) Sale 25,000 16.50 412,500
2015-01-29 Perkins Adelene Q (President & CEO) Sale 20,000 14.83 296,540
2014-12-15 Palombella Vito J. (Chief Scientific Officer) Sale 4,737 16.32 77,293
2014-12-15 Palombella Vito J. (Chief Scientific Officer) Option Ex 4,737 2.04 9,663
2014-11-26 Palombella Vito J. (Chief Scientific Officer) Sale 4,736 15.00 71,040
2014-11-26 Palombella Vito J. (Chief Scientific Officer) Option Ex 4,736 2.04 9,661
2014-10-03 Evnin Anthony B (Director) Option Ex 24,500 12.39 303,677
2014-09-30 Evnin Anthony B (Director) Sale 112,451 13.56 1,525,285
2014-09-03 Palombella Vito J. (Chief Scientific Officer) Sale 9,472 15.39 145,774
2014-09-03 Palombella Vito J. (Chief Scientific Officer) Option Ex 9,472 2.04 19,322
2014-07-01 Palombella Vito J. (Chief Scientific Officer) Sale 879 12.87 11,312
2014-03-06 Selby Norman C (Director) Option Ex 2,500 8.87 22,174
2014-02-25 Palombella Vito J. (Chief Scientific Officer) Sale 4,736 15.00 71,040
2014-02-25 Palombella Vito J. (Chief Scientific Officer) Option Ex 4,736 2.04 9,661
2014-01-02 Palombella Vito J. (Chief Scientific Officer) Sale 753 13.52 10,180
2013-12-02 Evnin Anthony B (Director) Sale 17,756 14.56 258,527
2013-11-27 Evnin Anthony B (Director) Sale 1,200 14.56 17,472
2013-11-26 Evnin Anthony B (Director) Sale 138,961 14.72 2,045,505
2013-11-25 Evnin Anthony B (Director) Sale 23,703 15.40 365,026
2013-09-27 Palombella Vito J. (Chief Scientific Officer) Sale 4,736 17.28 81,838
2013-09-27 Palombella Vito J. (Chief Scientific Officer) Option Ex 4,736 2.04 9,661
2013-09-13 Perkins Adelene Q (Pres & Chief Executive Officer) Sale 13,076 20.50 268,097
2013-09-12 Perkins Adelene Q (Pres & Chief Executive Officer) Sale 31,924 20.81 664,402
2013-06-20 Palombella Vito J. (Chief Scientific Officer) Sale 23,150 18.53 429,062
2013-06-20 Palombella Vito J. (Chief Scientific Officer) Option Ex 22,103 1.72 38,017
2013-04-16 Rosebay Medical Co L.p. (10% Owner) Sale 5,708,283 38.40 219,198,067
2013-04-16 Beacon Co (10% Owner) Sale 5,708,282 38.40 219,198,028
2013-03-06 Venuti Michael C (Director) Option Ex 6,250 16.80 105,000
2012-12-14 Selby Norman C (Director) Option Ex 2,500 8.87 22,174
2012-12-07 Perkins Adelene Q (Pres & Chief Executive Officer) Option Ex 175,997 7.10 1,250,106
2012-11-29 Evnin Anthony B (Director) Sale 4,832 24.62 118,959
2012-11-27 Evnin Anthony B (Director) Sale 17,648 25.28 446,176
2012-11-27 Evnin Anthony B (Director) Option Ex 58,657 7.81 458,228
2012-11-26 Lindblom Christopher M (See Remarks) Sale 13,885 25.73 357,274
2012-11-26 Lindblom Christopher M (See Remarks) Option Ex 13,885 12.06 167,522
2012-10-15 Selby Norman C (Director) Option Ex 5,000 8.87 44,349
2012-09-07 Rosebay Medical Co L.p. (10% Owner) Buy 5,416,565 14.50 78,540,192
2012-09-07 Beacon Co (10% Owner) Buy 5,416,565 14.50 78,540,192
2012-09-04 Santabarbara Pedro (Chief Medical Officer) Option Ex 9,200 6.50 59,800
2012-05-31 Holtzman Steven H (Director) Sale 57,573 13.01 749,024
2012-05-30 Holtzman Steven H (Director) Sale 10,958 13.00 142,454
2012-05-29 Holtzman Steven H (Director) Sale 189,303 13.00 2,460,939
2010-12-16 Perkins Adelene Q (Pres & Chief Executive Officer) Buy 25,000 6.07 151,800
2010-08-25 Perkins Adelene Q (Pres & Chief Executive Officer) Buy 5,349 4.99 26,691
2010-08-24 Perkins Adelene Q (Pres & Chief Executive Officer) Buy 44,651 4.89 218,343
2009-01-07 Rosebay Medical Co L.p. (10% Owner) Buy 1,000,000 15.00 15,000,000
2009-01-07 Beacon Co (10% Owner) Buy 1,000,000 15.00 15,000,000
2008-12-17 Perkins Adelene Q (Pres & Chief Business Officer) Buy 8,500 7.94 67,481
2008-12-16 Perkins Adelene Q (Pres & Chief Business Officer) Buy 700 7.42 5,190
2008-11-25 Perkins Adelene Q (Pres & Chief Business Officer) Buy 100 5.70 570
2008-11-24 Perkins Adelene Q (Pres & Chief Business Officer) Buy 21,941 6.08 133,510
2008-10-28 Adams Julian (President, R&D & CSO) Option Ex 137,413 2.76 379,259
2008-10-27 Holtzman Steven H (CEO) Option Ex 88,742 3.00 266,226
2008-08-27 Holtzman Steven H (President and CEO) Buy 22,103 7.40 163,562
2008-03-17 Perkins Adelene Q (EVP and Chief Business Officer) Buy 1,552 5.91 9,176
2007-09-14 Holtzman Steven H (Chairman and CEO) Buy 5,000 9.12 45,599
2007-06-15 Perkins Adelene Q (EVP and Chief Business Officer) Buy 10,000 10.64 106,380
2007-05-11 Perkins Adelene Q (EVP and Chief Business Officer) Buy 2,946 10.86 31,984
2007-05-10 Perkins Adelene Q (EVP and Chief Business Officer) Buy 2,500 10.83 27,075
2007-05-09 Perkins Adelene Q (EVP and Chief Business Officer) Buy 1,000 10.95 10,950
2007-05-07 Perkins Adelene Q (EVP and Chief Business Officer) Buy 4,000 10.89 43,564
2007-05-04 Perkins Adelene Q (EVP and Chief Business Officer) Buy 10,248 11.07 113,435
2007-05-03 Perkins Adelene Q (EVP and Chief Business Officer) Buy 900 11.24 10,119

Insider trading activities including stock purchases, stock sales, and option exercises of INFI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Infinity Pharmaceuticals, Inc. (symbol INFI, CIK number 1113148) see the Securities and Exchange Commission (SEC) website.